Soligenix gets orphan drug designation from European Commission for RiVax to prevent Ricin poisoning

This article was originally published here

The European Commission has granted orphan drug designation to the Soligenix recombinant modified ricin toxin A-chain subunit (the active pharmaceutical ingredient in RiVax) for the prevention of ricin poisoning.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply